Back to News
Market Impact: 0.2
IDEAYA Biosciences, Inc. (IDYA) Reports Q3 Loss, Tops Revenue Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechAnalyst Estimates
IDEAYA Biosciences reported a quarterly loss of $1.22 per share, $0.04 narrower than the Zacks Consensus Estimate of a $1.26 loss. This compared with earnings of $1.33 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.10
Ticker Sentiment
IDYA0.30
More News
- Truist cuts Ideaya Biosciences stock price target on revised estimates
- IDEAYA Biosciences Reports Financial Results for the Third Quarter 2026 and Provides a Business Update
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- AMD rides data center riches to ‘largest and most profitable’ quarter in history
- AMD’s OpenAI, Meta chip deals trigger $1 billion quarterly charge
- AMD forecasts quarterly revenue above estimates as data-center revenue hits record